Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul;12(7):e005122.
doi: 10.1161/CIRCOUTCOMES.118.005122. Epub 2019 Jul 9.

Privacy-Preserving Generative Deep Neural Networks Support Clinical Data Sharing

Affiliations

Privacy-Preserving Generative Deep Neural Networks Support Clinical Data Sharing

Brett K Beaulieu-Jones et al. Circ Cardiovasc Qual Outcomes. 2019 Jul.

Abstract

Background: Data sharing accelerates scientific progress but sharing individual-level data while preserving patient privacy presents a barrier.

Methods and results: Using pairs of deep neural networks, we generated simulated, synthetic participants that closely resemble participants of the SPRINT trial (Systolic Blood Pressure Trial). We showed that such paired networks can be trained with differential privacy, a formal privacy framework that limits the likelihood that queries of the synthetic participants' data could identify a real a participant in the trial. Machine learning predictors built on the synthetic population generalize to the original data set. This finding suggests that the synthetic data can be shared with others, enabling them to perform hypothesis-generating analyses as though they had the original trial data.

Conclusions: Deep neural networks that generate synthetic participants facilitate secondary analyses and reproducible investigation of clinical data sets by enhancing data sharing while preserving participant privacy.

Keywords: blood pressure; deep learning; machine learning; privacy; propensity score.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Median systolic blood pressure trajectories from initial visit to 27 mo.
Figure 2.
Figure 2.
Pairwise Pearson correlation between columns. A, Original and real data, (B) nonprivate and auxiliary classifier generative adversarial network (AC-GAN) simulated data, and (C) differentially private and AC-GAN simulated data (RZ, randomization visit; 1M, 1-mo visit; 2M, 2-mo visit; 3M, 3-mo visit; 6M, 6-mo visit; 9M, 9-mo visit; 12M, 12-mo visit; 15M, 15-mo visit; 18M, 18-mo visit; 21M, 21-mo visit; 24M, 24-mo visit; and 27M, 27-mo visit).
Figure 3.
Figure 3.
Clinician evaluation of synthetic data. A, Synthetic participant scored a 2 by clinician expert. B, Synthetic participant scored a 4 by clinician expert. C, Synthetic participant scored a 6 by clinician expert. D, Synthetic participant scored an 8 by clinician expert. E, Comparison of scores between real and synthetic participant (dotted red lines indicate means). F, Distribution of scores between real (blue) and synthetic (green) patients. BP indicates blood pressure.
Figure 4.
Figure 4.
Accuracy of models trained on synthetic participants vs real data. Line indicates performance on real data, which on average should provide the best possible performance; bar indicates performance of classifier trained on private synthetic participants; bottom of chart indicates random performance.
Figure 5.
Figure 5.
The value of delta as a function of epoch for different ε values. An ε value of 3.5 allows for 1000 epochs of training and δ<10−5.
Figure 6.
Figure 6.
Machine learning and statistical evaluation of synthetic data. A–D, Performance on transfer learning task by source of training data for each machine learning method. E, Pairwise Pearson correlation between columns for the original and real data. F, Pairwise Pearson correlation between columns for the private synthetic data. AUROC indicates area under the receiver operator characteristic; LR, logistic regression; RF, random forest.

References

    1. Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM. Statistics in medicine–reporting of subgroup analyses in clinical trials. N Engl J Med. 2007;357:2189–2194. doi: 10.1056/NEJMsr077003. - PubMed
    1. Home The SPRINT Data Analysis Challenge. The SPRINT Data Analysis Challenge n.d. https://challenge.nejm.org/pages/home. Accessed December 1, 2018.
    1. Wright JT, Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, Reboussin DM, Rahman M, Oparil S, Lewis CE, Kimmel PL, Johnson KC, Goff DC, Jr, Fine LJ, Cutler JA, Cushman WC, Cheung AK, Ambrosius WT SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2103–2116. doi: 10.1056/NEJMoa1511939. - PMC - PubMed
    1. Basu S, Sussman JB, Rigdon J, Steimle L, Denton B, Hayward R. Development and Validation of a Clinical Decision Score to Maximize Benefit and Minimize Harm from Intensive Blood Pressure Treatment 2017. https://challenge.nejm.org/posts/5815. Accessed April 19, 2019.
    1. Dagan N, Tsadok MA, Hoshen M, Arkiv A, Karpati T, Gofer I, Leibowitz M, Gilutz H, Podjarny E, Bachmat E, Balicer R. To Treat Intensively or Not – Individualized Decision Making Support Tool 2017. https://challenge.nejm.org/posts/5826. Accessed April 19, 2019.

Publication types

Substances